Medication info
Telito Tablet 40mg (Telmisartan)

Telito Tablet 40mg (Telmisartan)

Prescription medicationTabletOral
Ingredient · strength
Telmisartan›40mg / 1 tablet
Manufacturer / importer
Boryung BioPharma Co., Ltd.
Appearance
White or almost white, bilayered, convex, round tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 201901726 · Approved 2019.03.22 · Insurance code 670501460

Summary

Main use
Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients
Who takes it
Adults
Adult dose
1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, with or without food. For some patients, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Ingredients

Manufacturer
Boryung BioPharma Co., Ltd.

Efficacy & effects

Treatment of essential hypertension; prevention of cardiovascular disease in high-risk patients

  • Essential hypertension
View approved original text

This medication is used for the treatment of essential hypertension. It also helps reduce the risk of cardiovascular diseases such as coronary artery disease, stroke, and peripheral artery disease in patients over 55 years of age who are unable to use ACE inhibitors. It is particularly effective in lowering the risk of myocardial infarction, stroke, and death due to cardiovascular diseases. Therefore, this medication plays an important role not only in managing hypertension but also in preventing cardiovascular complications. It is used to improve patients' cardiovascular health and reduce disease risk.

How to take

Adult dose

1. Essential hypertension Adults: Telmisartan 40 mg should be administered orally once daily with water, with or without food. For some patients, 20 mg once daily may be effective. If necessary, the dose may be increased to 80 mg once daily. The maximum blood pressure-lowering effect is achieved 4 ∼ 8 weeks after starting treatment when the dose is increased. This medicine has an additional blood pressure-lowering effect when coadministered with thiazide diuretics such as hydrochlorothiazide. 2. Reduction of cardiovascular risk Adults: It is recommended that 80 mg of this medicine be administered orally once daily with water, with or without food. The risk-reduction effect on cardiovascular morbidity and mortality at doses below 80 mg has not been established. When starting treatment with this medicine to reduce cardiovascular risk, blood pressure monitoring is recommended, and appropriate adjustment of antihypertensive therapy may be required. ○ Patients with hepatic impairment Use with caution in patients with mild ∼ moderate hepatic impairment, and do not exceed 40 mg once daily.

Precautions

This medication can cause serious harm to the fetus and newborn during pregnancy, so it should be discontinued immediately upon confirmation of pregnancy. It should not be used in individuals allergic to this medication or its components, women who are pregnant or breastfeeding, patients with severe liver impairment, certain hereditary angioedema patients, and patients with diabetes or severe kidney dysfunction. Elderly patients or those with hyperkalemia, mild to moderate liver dysfunction, heart valve disease, gastrointestinal disorders, or renal artery hypertension should use this medication cautiously and consult healthcare professionals before administration. While taking this medication, various adverse reactions may occur, including infection, hypotension, liver dysfunction, renal impairment, angioedema, hyperkalemia, interstitial pneumonia, and rhabdomyolysis, so patients should inform their healthcare provider immediately if symptoms occur. In particular, if rapid drops in blood pressure, dizziness, fainting, difficulty breathing, or swelling of the face or lips occur, immediate medical attention should be sought. This medication may interact with other antihypertensive medications or specific drugs, so patients should inform their healthcare provider of any other medications they are taking. Patients with poor renal function should regularly check their serum potassium and creatinine levels, and those with reduced blood volume should be cautious of hypotension risk. Patients undergoing surgery should ideally discontinue this medication 24 hours before the procedure. This medication contains sorbitol; it should not be taken by patients with fructose intolerance. Caution should be exercised while driving or operating dangerous machinery as dizziness or fainting may occur. Safety and efficacy in pediatric patients under 18 years of age have not been established, and use is not recommended. In case of overdose, hypotension, abnormal heart rate, dizziness, and acute renal failure may occur, so the prescribed dosage should be strictly observed, and the patient should immediately visit a hospital if any abnormal symptoms arise. This medication should be stored out of reach of children, and transferring it to another container is not advisable for maintaining its quality.

Side effects

  • Upper respiratory infection
  • pharyngitis
  • sinusitis
  • urinary tract infection
  • cystitis
  • sepsis
  • anemia
  • thrombocytopenia
  • eosinophilia
  • hypersensitivity
Show 82 more
  • anaphylactic reaction
  • hyperkalemia
  • hypoglycemia
  • hyponatremia
  • depression
  • insomnia
  • anxiety
  • syncope
  • drowsiness
  • visual distortion
  • dizziness
  • bradycardia
  • tachycardia
  • hypotension
  • orthostatic hypotension
  • dyspnea
  • cough
  • interstitial lung disease
  • abdominal pain
  • diarrhea
  • dyspepsia
  • abdominal distension
  • vomiting
  • abdominal discomfort
  • dry mouth
  • dysgeusia
  • abnormal liver function
  • liver dysfunction
  • increased sweating
  • itching
  • rash
  • erythema
  • angioedema
  • drug rash
  • toxic skin rash
  • eczema
  • urticaria
  • myalgia
  • back pain
  • muscle cramps
  • arthralgia
  • limb pain
  • tendon pain
  • acute renal failure
  • chest pain
  • weakness
  • influenza-like illness
  • elevated serum creatinine
  • elevated serum uric acid
  • increased liver enzymes
  • elevated serum creatine kinase
  • decreased hemoglobin
  • facial spasms
  • sensory disturbances
  • paralysis
  • hyperventilation
  • pneumonia
  • flushing
  • erectile dysfunction
  • loss of appetite
  • arrhythmia
  • weakness
  • edema
  • decreased libido
  • facial edema
  • alopecia
  • conjunctivitis
  • tinnitus
  • petechia
  • headache
  • vertigo
  • palpitations
  • nausea
  • insufficient effect
  • arrhythmia
  • vascular edema
  • laryngeal edema
  • jaundice
  • shock
  • loss of consciousness
  • interstitial pneumonia
  • rhabdomyolysis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is best maintained at room temperature between 1 to 30 degrees Celsius to ensure the safety of the medication's effectiveness.

Appearance and packaging

Appearance

White or almost white, bilayered, convex, round tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.